Critical Lower Limb Ischemia Clinical Trial
Official title:
Randomised Clinical Study of Safety and Efficacy of Autologous Bone Marrow Aspirate Concentrate (BMAC) for No-option_critical Limb Ischemia in Type-II Diabetes Mellitus Patients. (DIALEG)
The aim of the presented clinical trial is to evaluate a hypothesis, that BMAC prepared from bone marrow aspirate and injected intramuscularly into ischemic areas of the lower extremity in patients with diabetes mellitus type II., intraarterially into the defect of the limb or with an intravenous application only, has a greater potential to improve the perfusion in the ischemic limbs than standard treatment of NO-CLI. Another aim of the study is to find out differences among three different therapeutic types of BMAC application, to define their effectiveness and safety and to compare the impact of different means of application to the speed of healing of the limb defects and the improvement of perfusion parameters.
Secondary hypothesis assumes, that the intravenous application of BMAC in patients with T2DM older than 30 years of age, with a dose of insulin exceeding 0.7 U/kg/day or 50U/day will result in decreasing the insulin dose in the course of 6-month follow-up and in an improvement of the glycHBA1c levels, improvement of the liver and kidney function, decrease of the cholesterol levels and improvement of the immune response parameters, i.e. parameters of lymphocytar blastic transformation, more than in case of patients with intramuscular or intraarterial application of BMAC. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04534257 -
Prospective Registry to Investigate the Safety and Efficacy of the Treatment With the Selution Sirolimus Drug Coated Balloon in TASC C and D Atheroma-occlusive Infra-Inguinal Disease in Patients With Chronic Limb Threatening Ischemia From Singapore
|
N/A | |
| Recruiting |
NCT02239419 -
Evaluation of Carbothera in the Treatment of Foot Ulcers
|
N/A | |
| Completed |
NCT00941733 -
Study of IN.PACT Amphirion™ Drug Eluting Balloon vs. Standard PTA for the Treatment of Below the Knee Critical Limb Ischemia
|
N/A | |
| Completed |
NCT00633659 -
Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia
|
Phase 2 | |
| Completed |
NCT04490408 -
Surgical Bypass Versus Hybrid Approaches for Critical Limb Ischemia
|
N/A | |
| Recruiting |
NCT04110327 -
An All-Comers Observational Study of the MicroStent™ Peripheral Vascular Stent System in Subjects With Peripheral Arterial Disease
|
||
| Recruiting |
NCT06075940 -
Evaluation of the MAGNITUDE® Bioresorbable Drug-Eluting Scaffold in the Treatment of Patients With Below the Knee Disease in Australia
|
N/A | |
| Completed |
NCT04058626 -
TEsting for Arterial Disease in Diabetes (TrEAD) Study
|
||
| Active, not recruiting |
NCT05009602 -
Diagnostic Tools to Establish the Presence and Severity of Peripheral Arterial Disease in People With Diabetes
|
||
| Completed |
NCT05436405 -
Trans-pedal Access for Endovascular Revascularization in Complex Infra-popliteal Lesions in Critically Ischemic Limb
|
N/A | |
| Completed |
NCT04107298 -
Safety and Feasibility of Surmodics SUNDANCE™ Drug Coated Balloon
|
N/A | |
| Active, not recruiting |
NCT06127134 -
Outcomes of Straight-line Flow Versus Angiosome-targeted Angioplasty in Treatment of Critical Lower Limb Ischemia
|
N/A | |
| Completed |
NCT04756115 -
Impact of Nutritional and Inflammatory Status in Patients With Critical Limb-threatening Ischemia
|
||
| Active, not recruiting |
NCT03970538 -
PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
|
N/A | |
| Recruiting |
NCT05455138 -
Allografts in Surgery of the Main Arteries
|
N/A | |
| Completed |
NCT03636867 -
Laboratory, Cellular and Molecular Determinants of Clinical Success in Diabetic Patients With Critical Limb Ischemia
|
||
| Active, not recruiting |
NCT01861327 -
The Use of Carbon Dioxide as a Contrast Media for Performing Endovascular Procedures
|
N/A |